气相色谱-质谱法分析树苔浸膏的成分

采用分子蒸馏法对树苔浸膏进行分级分离,用气相色谱-质谱法对各级馏分进行定性和定量分析。结果表明:三级馏分共鉴定出55种成分,主要成分是苔黑酚单甲醚、分歧扁枝衣素单甲醚、扁枝衣酸乙酯、柔扁枝衣酸甲酯、β-苔黑酚羧酸甲酯、赤星衣酸乙酯、苔黑酚羧酸乙酯、柔扁枝衣酸乙酯、棕榈酸乙酯、油酸乙酯、亚麻酸乙酯和亚油酸乙酯。     

固相微萃取-气相色谱-质谱法分析树苔浸膏的香气成分

采用固相微萃取-气相色谱-质谱法分离和鉴定树苔浸膏的香气成分,用归一化测定其相对含量。为使固相微萃取达到更高的效率,选用100μm PDMS的固相萃取头,萃取温度及时间为65℃和30min。共鉴定出62种化合物,其中33种为酯类化合物,占总香气成分峰面积的58%,为构成树苔浸膏典型苔清香香气特征的重要成分。     

高效液相色谱串联质谱法同时测定化妆品中苔黑醛和氯化苔黑醛

建立高效液相色谱串联质谱法同时测定化妆品中苔黑醛和氯化苔黑醛含量的方法。化妆品使用甲醇溶解后,超声提取15 min,离心分离后过膜,直接上机分析。目标物经ZORBAX SB-C_(18)色谱柱分离后,使用ESI源对其进行电离,在选择反应监测模式下绘制色谱图,以色谱峰面积外标法定量。苔黑醛和氯化苔黑醛的质量浓度在5~100μg/L范围内与色谱峰面积具有良好的线性关系,相关系数均大于0.999,苔黑醛和氯化苔黑醛的检出限均为10μg/kg。加标回收率为80.6%~89.8%,测定结果的相对标准偏差为1.1%~2.0%(n=6)。该方法可为化妆品中苔黑醛和氯化苔黑醛的筛查和测定提供一定的借鉴。     

柱前衍生-高效液相色谱法测定肥料中芸苔素内酯异构体

建立了以苯硼酸为衍生试剂,柱前衍生-高效液相色谱测定肥料中24-表芸苔素内酯(24-EBL)和28-高芸苔素内酯(28-HBR)的方法。样品采用甲醇作为提取溶剂,常温条件下用苯硼酸衍生30 min,乙腈/水(85/15, V/V)为流动相,在222 nm波长下进行分析。结果表明：在0～1250 mg/kg范围内线性关系良好,相关系数(r²)≥0.999。24-EBL和28-HBR的检出限分别为0.46和0.51 mg/kg。样品加标回收率为67.1%～128.5%,批间相对标准偏差为0.09%～2.4%。该方法满足2种芸苔素内酯异构体在肥料内定量分析的要求。     

化妆品中苔黑醛和氯化苔黑醛的超高效液相色谱法测定及质谱确证

采用超高效液相色谱建立了化妆品中苔黑醛和氯化苔黑醛的分析方法,并采用液相色谱-串联质谱法进行确证。化妆品试样采用5%三氯乙酸-乙腈混合溶液(70/30,V/V)超声提取15 min,离心过膜后即可直接上机分析。采用亚二微米超高效液相色谱柱分离,外标法定量;质谱确证采用水和乙腈作为流动相梯度洗脱,电喷雾负离子模式电离,多反应监测模式检测。苔黑醛和氯化苔黑醛在0.1~50 mg/L范围内线性关系良好(线性相关系数r≥0.9990),方法的定量限为5.0 mg/kg(信噪比为10)。膏霜、乳液和香水等样品在5.0,10,25 mg/kg的添加回收率在87.4%~96.3%之间,RSD(n=6)为1.4%~4.6%。方法适用于化妆品中苔黑醛和氯化苔黑醛的检测及其含量水平的普查。     

新型绿色植物生长调节剂——芸苔素内酯的研究进展*

芸苔素内酯是一种新型绿色环保植物生长调节剂,具有促进植物生长、提高植物抗逆抗病能力、改善植物生长品质等多方面功能,被视为第六类植物生长激素。概述了芸苔素内酯的研究进展,介绍了芸苔素内酯在农业生产中的应用,为推动芸苔素内酯的广泛使用提供参考。     

高效液相色谱法检测噻虫嗪-氟虫腈悬浮剂

采用高效液相色谱法测定农药复合制荆120 g/L噻虫嗪-60 g/L氟虫腈悬浮荆.采用ODS C18反相色谱柱(150 mm×4. 6 mm i. d. ,5μm),乙腈一水(体积比为4∶6)为流动相,用紫外检测器在240 nm波长下,对试样中的噻虫嗪和氟虫腈进行分离和定量检测.噻虫嗪、氟虫腈的平均回收率分别为99. 0%～102. 0%、96. 0%～104. 0%,测定结果的相对标准偏差分别为0. 5%、1. 6%(n=6).     

草玉梅中的化学成分

从草玉梅根部和地上部分甲醇提取物中分离到的8个化合物,其中三萜内酯(7)和三萜皂甙(8)为新化合物.     

液相色谱-串联质谱法测定果蔬中双三氟虫脲、四氯虫酰胺和氰虫酰胺残留

建立了蔬菜和水果中双三氟虫脲、四氯虫酰胺和氰虫酰胺3种新型杀虫剂的分散固相萃取-液相色谱-串联质谱检测方法.样品经乙腈均质提取,混合使用乙二胺-N-丙基硅烷(PSA)和C18基质分散净化剂进行净化,液相色谱-三重四极杆串联质谱(LC-MS/MS)同时进行检测.双三氟虫脲和四氯虫酰胺采用多反应监测负离子模式,氰虫酰胺采用多反应监测正离子模式.双三氟虫脲在苹果、洋葱和经微波处理的洋葱样品中均不存在基质效应,可采用纯溶剂标准外标法或者采用基质匹配标准溶液定量检测; 四氯虫酰胺和氰虫酰胺存在程度不同的基质减弱效应,采用空白基质匹配的校正标准曲线外标法定量.3种杀虫剂均在0.2～100 μg/L线性范围内具有良好的线性关系,相关系数均大于0.9990.在0.005～2.000 mg/kg范围内,平均添加回收率为81.6％～99.9％,相对标准偏差为3.6％～9.8％.氰虫酰胺、四氯虫酰胺和双三氟虫脲的检出限分别为0.064,0.048和0.001 μg/kg,定量限分别为0.210, 0.160和0.004 μg/kg.     

液相色谱串联质谱法测定果蔬中的唑虫酰胺、氟啶虫酰胺、氯虫苯甲酰胺及氟虫双酰胺残留

建立了同时测定蔬菜和水果中唑虫酰胺、氟啶虫酰胺、氯虫苯甲酰胺和氟虫双酰胺残留量的液相色谱-串联质谱(LC-MS/MS)分析方法。样品经乙腈提取,过滤后进行盐析,上层有机相经QuEChERS方法净化浓缩后,用乙腈-水(体积比20∶80)定容进行分析。采用XBridgeTMC18色谱柱,以0.1%甲酸溶液-乙腈体系进行梯度洗脱,MRM方式测定,基质外标法定量。在优化条件下,唑虫酰胺和氟啶虫酰胺的线性范围为0.075~2.0 mg.L-1,氯虫苯甲酰胺和氟虫双酰胺为0.015~0.40 mg.L-1,线性相关系数均不低于0.998。唑虫酰胺、氟啶虫酰胺、氯虫苯甲酰胺及氟虫双酰胺在蔬菜和水果样品中的检出限(S/N=3)为0.000 8、0.005、0.002、0.000 5 mg.kg-1。蔬菜和水果中4种农药在0.05~5.0 mg.kg-1(氟啶虫酰胺和唑虫酰胺)和0.01~1.0 mg.kg-1(氟虫双酰胺和氯虫苯甲酰胺)加标范围内的回收率为80%~95%,批内RSD为2.0%~6.1%,批间RSD为3.3%~7.6%。     

Identifying bryostatins and potential precursors from the bryozoan Bugula neritina

The bryozoan species Bugula neritina contains the anticancer agent bryostatin. Bryostatin has been extracted from these sessile marine invertebrates since the late 1960s from the Gulf of California, Gulf of Mexico, as well as various locations on the eastern and western rims of the Pacific Ocean. In this work we are focusing on animals harvested in the Gulf of Mexico near Alligator Point (Florida). Using Inductively Coupled Plasma-Mass Spectrometry (ICP-MS) we measure the concentration of 70 elements in B. neritina, a sea squirt, and the sediment from the point of harvesting. This data has helped us generate an extraction process for marine natural products. Combining UV/VIS absorbance measurements with Matrix Assisted Laser Desorption Ionization-Time of Flight-Mass Spectrometer (MALDI-TOF-MS), we demonstrated that the specific form of bryostatin extracted is a function of the solvent. A 9.4T Fourier Transform-Ion Cyclotron Resonance (FT-ICR) mass spectrometer, whose sensitivity, mass accuracy, and resolving power allowed the exact empirical formulas of potential precursors of bryostatin to be identified, was employed. Finally we examine extracts of 14 marine species of the Gulf of Mexico, from the sand trout (Cynoscion arenarius) to chicken liver sponge (Chrondrilla nucula), all recently collected, which had shown some medicinal activity thirty years ago in a National Cancer Institute study. By the MALDI-TOF-MS, we were able to identify mass spectral features that correspond to different variations of the basic bryostatin structure, which raises the question if the bryozoans are the original source of bryostatin.     

Impact of environmental conditions on the marine natural product bryostatin 1

Marine Natural Products (MNPs), such as bryostatin 1, are exposed to a range of physical and chemical conditions through the life cycle of the host organism. These include exposure to sunlight, oxidizing and reducing agents, cation binding, and adsorption to reactive metal oxide surfaces. Using Fourier Transform-Ion Cyclotron Resonance (FT-ICR), Matrix Assisted Laser Desorption Ionization Mass Spectrometry (MALDI-MS), UV/Vis absorbance spectroscopy, and molecular modeling, we studied the impact of UV light, TiO2, I2, and reaction with FeCl3 on the structure of bryostatin 1. Our results demonstrate that natural conditions transform bryostatin to a number of structures, including one with a molar mass of 806 Da, which we have previously identified in the sediment collected from the Gulf of Mexico. To date, at least 20 different structures of bryostatin have been reported in the literature. This work suggests that these variations may be products of the chemical environment in which the bryozoa Bugula neritina resides and are not the result of genetic variations within Bugula.     

Antineoplastic agents 100: The marine bryozoan Amathia convoluta

An intensive investigation of the marine animal AAmathia convoluta (Bryozoa phylum) for antineoplastic constituents has led to the isolation and structural determination of bryostatin 8 (2). A total of 100 kg of Amathia convoluta was required to obtain some 4.2 mg of bryostatin 8. Evaluation of bryostatin 8 against the murine P388 lymphocytic leukemia showed substantial inhibition of growth (PS, cell line ED₅₀, 1.3 × 10^-3, T/C 174 at 0.11 $\text{mg}\text{kg}$). A major part of the very strong antineoplastic activity exhibited by fractions prepared from Amathia convoluta was accounted for by the isolation of bryostatins 4 (1a), 5 (1c) and 6 (1b). All three bryostatins were obtained in yields comparable to that of bryostatin 8 and appear derived from the closely related marine bryozoan Bugula neritina. The epiphytic-like relationship of Bugula neritina to Amathia convoluta is discussed.     

bryA: an unusual modular polyketide synthase gene from the uncultivated bacterial symbiont of the marine bryozoan Bugula neritina

"Candidatus Endobugula sertula," the uncultivated bacterial symbiont of Bugula neritina, is the proposed source of the bryostatin family of anticancer compounds. We cloned a large modular polyketide synthase (PKS) gene complex from "Candidatus Endobugula sertula" and characterized one gene, bryA, which we propose is responsible for the initial steps of bryostatin biosynthesis. Typical PKS domains are present. However, acyltransferase domains are lacking in bryA, and beta-ketoacyl synthase domains of bryA cluster with those of PKSs with discrete, rather than integral, acyltransferases. We propose a model for biosynthesis of the bryostatin D-lactate starter unit by the bryA loading module, utilizing atypical domains homologous to FkbH, KR, and DH. The bryA gene product is proposed to synthesize a portion of the pharmacologically active part of bryostatin and may be useful in semisynthesis of clinically useful bryostatin analogs.     

Detection and Quantitation of Bryostatin 1 and 2 in Bugula Neritina by Combined High-Peformance Liquid Chromatography and 3H-Phorbol Dibutyrate Displacement

Abstract

An HPLC method has been developed to detect and quantitate bryostatins 1 and 2 from crude extracts of B. neritina. This, coupled with a ³H-phorbol dibutyrate binding assay and photodiode array-acquired uv spectra makes possible the evaluation of crude extracts in a rapid, sensitive and specific manner.     

Secondary metabolites from marine bryozoans. A review

Secondary metabolites from marine bryozoans are reviewed. Two ctenosome bryozoans are dealt with, one, Alcyonidium gelatinosum containing a sulfoxonium ion acting as hapten in an allergic contact dermatitis and the other, Zoobotryon verticillatum yielding bromogramines. Five cheilostome bryozoans have given rise to the isolation of unique secondary natural products. Bugula neritina is the source of the antineoplastic bryostatins and Bugula purple while Flustra foliacea have yielded an array of bromoindole alkaloids and a brominated quinoline. Chartella papyracea also have bromoindole alkaloids while Sessibugula translucens have ecological active bipyrroles. A biological active xanthine derivative has been reported from Phidolopora pacifica. The structure and chemistry of these compounds are discussed as are their origin, function and biological activity.     

A preliminary evaluation of a metathesis approach to bryostatins

Preliminary investigations into the synthesis of bryostatins using ring-closing metathesis to form the C(16)-C(17) double bond led to a synthesis of the bryostatin analogue 51; precursors 26 and 52, which possess the geminal dimethyl group at C-18, did not undergo the required ring-closing metathesis.     

Diverse synthesis of the C ring fragment of bryostatins via Zn/Cu-promoted conjugate addition of α-hydroxy iodide with enone

A convergent approach to 1,5-hydroxy ketones,the general precursors for constructing the C ring of bryostatins,has been developed via a Zn/Cu-promoted conjugate addition of a-hydroxy iodides with enones.The reaction leads to direct formation of the C21-C22 bond and tolerates diverse functionalities at the C17-,C18-and C24-positions.The approach also enables a more concise synthesis of the known C ring intermediate(10 longest linear steps and 14 total steps),in contrast to its previous synthesis(17 longest linear steps and 22 total steps) in our total synthesis of bryostatin 8.     

Quantitative analysis of EO9 (apaziquone) and its metabolite EO5a in human plasma by high-performance liquid chromatography under basic conditions coupled to electrospray tandem mass spectrometry

A sensitive and specific LC-MS/MS assay for the quantitative determination of EO9 and its metabolite EO5a is presented. A 200-microl human plasma aliquot was spiked with a mixture of deuterated internal standards EO9-d3 and EO5a-d4 and extracted with 1.25 ml ethyl acetate. Dried extracts were reconstituted in 0.1 M ammonium acetate-methanol (7 : 3, v/v) and 25 microl-volumes were injected into the HPLC system. Separation was achieved on a 150 x 2.1 mm C18 column using an alkaline eluent (1 mM ammonium hydroxide-methanol (gradient system)). Detection was performed by positive ion electrospray followed by tandem mass spectrometry. The assay quantifies a range from 5 to 2500 ng/ml for EO9 and from 10 to 2500 ng/ml EO5a using 200 microl of human plasma samples. Validation results demonstrate that EO9 and EO5a concentrations can be accurately and precisely quantified in human plasma. This assay will be used to support clinical pharmacologic studies with EO9.     

Unlocking the Drug Potential of the Bryostatin Family: Recent Advances in Product Synthesis and Biomedical Applications

Bryostatins are a class of naturally occurring macrocyclic lactones with a unique fast developing portfolio of clinical applications, including treatment of AIDS, Alzheimer's disease, and cancer. This comprehensive account summarizes the recent progress (2014–present) in the development of bryostatins, including their total synthesis and biomedical applications. An emphasis is placed on the discussion of bryostatin 1 , the most-studied analogue to date. This review highlights the synthetic and biological challenges of bryostatins and provides an outlook on their future development.